BioSpace News Archive

CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced changes to its Supervisory Board.

NGM Biopharmaceuticals, Inc. (NGM or the Company) (Nasdaq: NGM), a biotechnology company focused on developing transformative therapeutics for patients, today reported financial results for the fourth quarter and year ended December 31, 2019 and business highlights.

Johnson & Johnson will host a conference call for investors at 8:30 a.m. on Tuesday, April 14th to review first-quarter results. Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call.

Dover announced that it has entered into a definitive agreement to acquire Em-tec GmbH, a leading designer and manufacturer of flow measurement devices that serve a wide array of medical and biopharmaceutical applications.

McKesson Corporation announced it is updating its adjusted earnings outlook for the fiscal year ending March 31, 2020 to reflect the completion of the company’s exit of its investment in Change Healthcare, as announced on March 10, 2020.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to dramatically ramp up global production capacity of RNA extraction kits that are used as part of workflows around the world to detect nucleic acid from SARS-CoV-2, the novel coronavirus that causes COVID-19.

As the COVID-19 global pandemic continues to evolve, pharmacists are becoming increasingly mindful about the need to carefully manage our drug supply to weather some of the long-term impacts of the disease across the globe.

MiMedx Group, Inc. announced the filing of its 2018 Annual Report, which includes the Company’s audited consolidated statements of operations, and stockholders’ equity and cash flows for the years ended December 31, 2018 and 2017, which the Company did not previously file, and for the year ended December 31, 2016, which the Company has restated.

Urban One’s 12th annual fundraising broadcast to benefit patients battling cancer and other life-threatening diseases raised more than $1.5 million this month for St. Jude Children’s Research Hospital®.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced that it has appointed Jane E. Kiernan to its board of directors, effective March 12, 2020.